Lingering echoes of SARS-CoV-2: mechanistic insights and management of long COVID syndrome
- 30 November 2025
- journal article
- review article
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (1) , 17-46
Abstract
Throughout the world-wide COVID-19 pandemic, there has arisen a significant and a sustained public-health issue, whereby a significant proportion of individuals report persistent symptoms, well beyond the acute period of infection. The non-united array of chronic, multisystemic events, such as fatigue, cognitive deficit, respiratory dysfunction, cardiovascular abnormalities, and neuropsychiatric disorders characterize this sequela, which is referred to as LCS. LCS is much more than the starting viral insult, as it causes long-term complications that impact various organ systems. The current review questions the pathophysiological mechanisms of LCS, including scrutinizing the importance of the dysregulation of immunity, the persistence of viral reservoirs, endothelial dysfunction, autonomic imbalance, and mitochondrial injury. We highlight the heterogeneity of the syndrome and the associated diagnostic and treatment difficulties. In addition, we stress the urgency of powerful biomarkers that will be used to diagnose LCS as early as possible and monitor it over time. Present treatment strategies, including pharmacologic therapy (immunomodulators, anticoagulants, antiviral medications, etc.) and non-pharmacologic treatment (rehabilitative programs, etc.) are discussed against the backdrop of recent clinical findings. This review incorporates the recent literature and presents a review of potential treatment options that alleviate symptoms and improve the quality of life of LCS patients. Finally, this integrated synthesis can be used by both clinicians and researchers to gain practical information on the diagnosis, treatment, and future treatment directions of LCS.Keywords
This publication has 260 references indexed in Scilit:
- The Role of Anticoagulation in COVID-19-Induced HypercoagulabilityCurrent Cardiology Reports, 2020
- COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugsBritish Journal of Ophthalmology, 2020
- Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health scienceThe Lancet Psychiatry, 2020
- Hematological findings and complications of COVID‐19American Journal of Hematology, 2020
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort studyIntensive Care Medicine, 2020
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialThe Lancet, 2020
- Clinical and immunological features of severe and moderate coronavirus disease 2019Journal of Clinical Investigation, 2020
- The Role of Adipose Tissue and Adipokines in Sepsis: Inflammatory and Metabolic Considerations, and the Obesity ParadoxCurrent Obesity Reports, 2019
- Kinetics of circulating fetuin-A may predict mortality independently from adiponectin, high molecular weight adiponectin and prognostic factors in critically ill patients with sepsis: A prospective studyJournal of Critical Care, 2017
- Hypocalcemia, Hypomagnesemia, and Hypokalemia Following Hydrofluoric Acid Chemical InjuryJournal of Burn Care & Research, 2008